Clinical Trial

Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The Impact of Health Literacy on the Attitudes toward Pharmacological Treatment in Patients with Schizophrenia Spectrum Disorder This interventional study is aimed at: * assessing and improving the health literacy and * assessing the attitude towards treatment of patients with schizophrenia spectrum disorders while they are admitted to the inpatient psychiatric unit.
Trial Details
NCT Number NCT07488156
Lead Sponsor Louisiana State University Health Sciences Center in New Orleans
Collaborators: Janssen Pharmaceuticals
Conditions Schizophrenia Disorder, Schizoaffective Disorder, Psychosis
Enrollment 34 participants
Start Date 2026-03-01
Primary Completion 2027-07-30 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-23